Špokienė, Indrė
Constitutional guarantees of the right to healthcare of Lithuanian citizensItem type:Publication, research article[2014][S5][S001][11]Collection of scientific papers : research articles 2013 : Economics. Communication sciences. Political science. Sociology. Social policy and social work. Law / Rīga Stradiņš University. Riga : Rīga Stradiņš University, 2014. ISBN 9789984793597., P. 66-76The effectiveness of the implementation of the right to healthcare relates directly with legal clarity and certainty of its contents. This Paper focuses on the issue of obligations of the state with the view of the implementation of the constitutional right to healthcare of Lithuanian citizens. A very important source of analysis is the new official constitutional doctrine. The Paper reveals the contents of the principle “state takes care of people’s health” of the Constitution of the Republic of Lithuania, which safeguards the right of the citizens to the best attainable health. Two other guarantees to healthcare have been analysed: the right of citizens to free-of-charge medical aid and their right to other healthcare services. The analysis reveals that the obligations of Lithuania towards its citizens are not related with the guarantees of physical, mental and social health (admittedly, the maximum implementation of them to every citizen would be a utopian promise). Rather, they are predominantly related with providing legal and organizational preconditions for functioning of such a health protection system, which ensures quality and accessible healthcare services for individuals and the public. The aid vitally important for life must be provided unconditionally and for free at the state medical establishments. The obligations of Lithuania with respect to its citizens’ right to healthcare are bound by such constitutional values as human life and dignity. The extent of obligations is legally limited by the state’s economic and social situation, the needs and capacities of the society and the state, and financial resources.
9 Kai kurie netradicinei medicinai priskiriamų paslaugų teisinio reguliavimo Lietuvoje ypatumaiItem type:Publication, [Some aspects of legal regulation of unconventional medicine services in Lithuania]conference paper[2012][P1e][S001][4]Į sveiką gyvenseną ir skaidrią būtį Vydūno keliu : šių metų tema Visuomeninė sąmonė ir lėtinių neinfekcinių ligų valdymas : tarptautinė mokslinė-praktinė konferencija : programa ir konferencijos medžiaga / Klaipėdos universitetas. Klaipėda : Klaipėdos universiteto leidykla, 2012. ISBN 9789955186380., P. 110-1139 Nepilnamečių akušerinės ir ginekologinės sveikatos priežiūros teisinio reguliavimo aspektaiItem type:Publication, [Legal aspects of obstetric and gynecological care to minors]research article[2011][S4][M001][10] ;Vasjanova, Vilma; Denafaitė-Jaseliūnienė, GintarėLietuvos akušerija ir ginekologija = Lithuanian Obstetrics & Gynecology : ketvirtinis žurnalas / Lietuvos akušerių ir ginekologų draugija. Kaunas : Vitae litera, 2011, t. 14, Nr. 4 (gruodis)., p. 297-306Straipsnyje nagrinėjamas nepilnamečių pacientų asmens sveikatos priežiūros teisinis reguliavimas, išryškinant probleminius praktinius akušerijos ir ginekologijos paslaugų teikimo paauglėms aspektus.
11 Legal assessment of current situation on orphan patients in LithuaniaItem type:Publication, [Retomis ligomis sergančių pacientų situacijos Lietuvoje teisinis vertinimas]research article[2008][S1][S001,M001][6]Medicina. Kaunas : Kauno medicinos universitetas, 2008, t. 44, Nr. 8., p. 571-576After Lithuania joined the European Union, the Regulation (EC) No. 141/2000 on orphan medicinal products and Commission Regulation (EC) No. 847/2000 came into force as part of national legislation. Member States must adopt specific measures to increase knowledge on rare diseases and to improve their detection, diagnosis, and treatment. The aim of this article was to present and to assess the current legal situation on orphan patients and their treatment in Lithuania, to identify legislation gaps, and to propose some ideas how to facilitate the solution of the existing problems in this field For this purpose, European Union and Lithuanian legal documents on rare medicinal products are examined using a comparative method with reference to inventory of Member States' incentives for rare diseases in national level, the most important issues, which orphan patients face to in Lithuania, are singled out. In Lithuania, the situation of orphan patients in terms of protection of patient rights is insufficiently determined. The access to effective health care services or approved therapies in some cases is restricted Working relationships between genetic services and various clinical specialists as well as with those in primary care are not legally determined; the number of clinical trials aimed at orphan medicinal products is low. These results suggest a need for awareness raising among Lithuanian Government, health care specialists, patient organizations about the importance to improve practical implementation of European Union legislation and progressive experience of some European countries in this field.
7 Europos Bendrijos retųjų vaistinių preparatų registras: [metodinis vadovas]Item type:Publication, book[2007][K2c][S001,M001,M003][193]; ; Vilnius: Vilniaus universiteto leidykla, 2007Šis leidinys skirtas gydytojams, sveikatos priežiūros specialistams, visiems, kuriuos domina retų ligų ir retųjų vaistų tema. Į lietuvių kalbą išverstas ir atitinkamai susistemintas Bendrijos retųjų vaistinių preparatų registras. Jau registruotų vaistinių preparatų, kuriems suteiktas prekinio ženklo pavadinimas, paieška palengvinta – sudarytos rodyklės lietuvių ir anglų kalbomis pagal retų ligų ar būklių indikacijų terminus. Pristatomos retos ligos ir retojo vaisto sampratos, supažindinama su ES galiojančia vaistų priskyrimo retiesiems tvarka, pristatomos valstybių narių iniciatyvos sprendžiant retų ligų ir vaistų joms gydyti trūkumo problemą.
6 Access to information supporting availability of medicines for patients suffering from rare diseases looking for possible treatments: the EuOrphan ServiceItem type:Publication, [EuOrphan paslauga – informacija apie vaistų, skirtų gydyti sergančiuosius retomis ligomis, prieinamumą]research article[2007][S1a][S001,M001][5]; ; ; ;Valuckas, Konstantinas PovilasBaiardi, PaolaMedicina. , 2007, T. 43, Nr. 6., p. 441-445Currently in Europe, approximately 30 million people suffer from rare diseases, and a major problem is that many patients do not have access to quality healthcare for their disorders. Moreover, there is also a lack of quality information and a networking system aimed at supporting interaction among patients, clinicians, researchers, pharmaceutical industries, and governmental bodies. The purpose of this article is to inform physicians, public health care professionals, and other health care providers about EuOrphan service, the aim of which is to ensure easier access to quality information on rare diseases and their treatment. A set of web-based services is available at www.euorphan.com where information for target-users on treatments and products available worldwide for rare disease care as well as indications about healthcare centers are provided. Moreover, the service aims at providing consultancies for pharmaceutical companies to ultimately support the European legislation in bringing new drugs of a high ethical standard to the market and to exert a positive impact on the large population of patients suffering from rare diseases in Europe. The services provided by EuOrphan can facilitate concrete networking among patients, patient associations, doctors, and companies and also support the organization of clinical trials. In this perspective, EuOrphan could become a very valuable tool for globalizing the information about the availability of treatment (authorized or under development) of orphan patients.
6 Orphan patients and orphan medicines : situation in LithuaniaItem type:Publication, research article[2007][S4][S001,M001,M004][1]Neurologijos seminarai. 9-oji tarptautinė Baltijos šalių vaikų neurologų asociacijos konferencija 2007 m. birželio 20-23 d., Vilnius, Lietuva. Vilnius : Rotas, 2006, T. 11, Priedas Nr. 1., p. 267 Retos ligos ir retieji vaistai: metodinis vadovas; Mykolo Romerio universitetasItem type:Publication, book[2006][K2b][S001,M001][163]; ; Vilnius: MRU Leidybos centas, 2006Metodinis nurodymas, skirtas gydytojams, sveikatos priežiūros specialistams. Taip pat kaip mokymo priemone šiuo metodiniu vadovu gali naudotis bioteisę studijuojantys studentai. Jame nagrinėjami retųjų vaistų sričiai skirti teisės aktai bei pateikiami ES reglamentų tekstų autentiški vertimai, supažindinama su ES galiojančia vaistų priskyrimo retiesiems tvarka, įvardijamos problemos, su kuriomis susiduria retomis ligomis sergantys pacientai. Išverstas ir atitinkamai susistemintas Bendrijos retųjų vaistinių preparatų registras.
17